Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.

immunogenicity infection block hypothesis infection history influenza test negative design vaccine waning vaccine protection

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
27 Sep 2023
Historique:
pubmed: 6 4 2023
medline: 6 4 2023
entrez: 5 4 2023
Statut: epublish

Résumé

Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees. This effect might arise from incomplete consideration of within-season waning and recent infection. Using data from the US Flu Vaccine Effectiveness (VE) Network (2011-2012 to 2018-2019 seasons), we found that repeat vaccinees were vaccinated earlier in a season by one week. After accounting for waning VE, repeat vaccinees were still more likely to test positive for A(H3N2) (OR=1.11, 95%CI:1.02-1.21) but not for influenza B or A(H1N1). We found that clinical infection influences individuals' decision to vaccinate in the following season while protecting against clinical infection of the same (sub)type. However, adjusting for recent clinical infections did not strongly influence the estimated effect of prior-season vaccination. In contrast, we found that adjusting for subclinical infection could theoretically attenuate this effect. Additional investigation is needed to determine the impact of subclinical infections on VE.

Identifiants

pubmed: 37016669
doi: 10.1101/2023.03.12.23287173
pmc: PMC10071822
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : 75N93019C00051
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM139926
Pays : United States

Auteurs

Qifang Bi (Q)

University of Chicago, Chicago, Illinois, USA.

Barbra A Dickerman (BA)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Huong Q McLean (HQ)

Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.

Emily T Martin (ET)

University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

Manjusha Gaglani (M)

Baylor Scott & White Health, Temple, Texas, USA.
Texas A&M University College of Medicine, Temple, Texas, USA.

Karen J Wernli (KJ)

Kaiser Permanente Bernard J. Tyson School of Medicine, Seattle, Washington, USA.

G K Balasubramani (GK)

University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.

Brendan Flannery (B)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Marc Lipsitch (M)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Sarah Cobey (S)

University of Chicago, Chicago, Illinois, USA.

Classifications MeSH